Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Endocrinology · Non-Classic Congenital Adrenal Hyperplasia

Can Non-Classic CAH Affect Fertility and Pregnancy?

At a Glance

Non-classic CAH can make pregnancy harder when excess adrenal hormones disrupt ovulation, but many women conceive naturally or with treatment. Seek fertility help early if periods are irregular, and plan medications and genetic counseling before pregnancy.

Having Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) can make getting pregnant more difficult for some women due to irregular ovulation. However, it is important to know that many women with NC-CAH conceive and have healthy pregnancies. The goal of this page is to help you understand how NC-CAH affects fertility, what treatments are available if you need them, and how to safely manage your care before and during pregnancy.

How NC-CAH Affects Fertility

In women with NC-CAH, a genetic enzyme deficiency causes the adrenal glands to produce higher-than-normal levels of 17-hydroxyprogesterone (17-OHP) and related steroid precursors, along with androgens (often called male hormones, though everyone has them) [1].

This hormonal imbalance can interfere with the normal menstrual cycle, leading to oligo-ovulation (infrequent or irregular ovulation) or a complete lack of ovulation [1]. Without a predictable release of an egg, conceiving becomes challenging.

However, observational data provides an encouraging picture. In a retrospective study of 75 women with NC-CAH actively seeking fertility treatment, 96% were able to conceive, though this specific group may not represent every individual’s chances [2]. In another cohort of women with NC-CAH, nearly half of the reported pregnancies occurred naturally without the use of medication [3].

When to seek help: The standard advice to “try for a year” before seeing a fertility specialist does not apply if your periods are absent or very irregular. If you are not having regular menstrual cycles, you should seek a fertility evaluation sooner.

Medical Interventions to Help You Conceive

If you are struggling to conceive, treatment is highly individualized. Not every woman with NC-CAH needs medication, and those who ovulate regularly are generally not advised to take steroids solely because of their diagnosis. Your doctor will evaluate your age, ovarian reserve, fallopian tubes, and your partner’s semen to rule out other causes of infertility before deciding on a treatment plan.

  • Low-Dose Glucocorticoids: A glucocorticoid is a cortisol-like steroid medicine. For women who are not ovulating due to excess adrenal hormones, a low dose of a glucocorticoid (such as hydrocortisone) can help lower 17-OHP and androgens [4]. In observational studies, this treatment regularized menstrual cycles in about two-thirds of women [3].
    • Caution: Glucocorticoids carry risks such as weight gain, elevated blood pressure, increased blood sugar, and bone thinning [5]. They should be prescribed at the lowest effective dose, carefully supervised by an endocrinologist, and the response should be tracked by confirming ovulation, not just cycle regularity [1].
  • Ovulation-Inducing Medications: If adrenal hormonal control does not restore ovulation, the next step may involve medications to stimulate the ovaries. Clomiphene citrate is historically cited as an option for NC-CAH [4]. Letrozole is also used, though its strong evidence base comes primarily from treating Polycystic Ovary Syndrome (PCOS), and it is less specifically studied for NC-CAH [6].
  • Assisted Reproductive Technology (ART): If other methods are unsuccessful, or if there are other fertility factors (like blocked tubes or sperm issues), In Vitro Fertilization (IVF) is an option. IVF involves retrieving eggs, fertilizing them in a lab, and transferring the embryo to the uterus [4].

Miscarriage Risk and Pregnancy Safety

Women with NC-CAH may have a slightly higher risk of early miscarriage compared to the general population [7]. Some observational studies suggest that taking glucocorticoids may help lower this risk, but the evidence is inconsistent and largely based on past clinical experience rather than definitive trials [7] [2]. Because of this uncertainty, glucocorticoids are not a universal “miscarriage prevention” treatment.

If you get a positive pregnancy test, it is critical to follow these safety steps:

  1. Do not stop or change medications on your own: Abruptly stopping a prescribed glucocorticoid can be dangerous and cause adrenal insufficiency.
  2. Contact your team immediately: Coordinate with your endocrinologist and obstetric team. They will review your medications. Steroids like hydrocortisone or prednisolone are generally preferred during pregnancy. Medications like dexamethasone cross the placenta and are generally avoided unless prescribed for a very specific fetal indication [8].
  3. Plan for stress-dosing: If you are on chronic glucocorticoid therapy or have documented adrenal insufficiency, you may need a “stress-dose” plan (extra medication) for severe illness, major trauma, or labor and delivery [5] [9].

The Importance of Preconception Genetic Counseling

Because NC-CAH is a genetic condition usually caused by variants in the CYP21A2 gene, preconception genetic counseling is highly recommended [1] [10].

Whether a child will have no CAH, non-classic CAH, or the more severe classic CAH depends entirely on the exact combination of genetic variants inherited from both parents [10]. Your partner should undergo validated carrier testing [1]. Because the CYP21A2 gene is complex, this often requires specialized genetic sequencing rather than a simple, basic carrier panel. A genetic counselor can interpret your partner’s results alongside your own genetic report to give you an accurate picture of your family’s risk. If both partners carry high-risk mutations, IVF with genetic testing of the embryos is an option to consider [4].

Common questions in this guide

Can I get pregnant if I have non-classic CAH?
Yes. Non-classic CAH can make conception more difficult when excess adrenal hormones disrupt ovulation, but many women become pregnant naturally or with fertility treatment. Your individual chances depend on ovulation and other factors affecting fertility.
When should I seek fertility help with non-classic CAH?
If your periods are absent or very irregular, seek a fertility evaluation without waiting a full year. Your care team may assess ovulation, ovarian reserve, fallopian tubes, and your partner’s semen to identify all possible causes of difficulty conceiving.
Can glucocorticoids help me ovulate with non-classic CAH?
A low dose of a glucocorticoid, such as hydrocortisone, may help some women ovulate when excess adrenal hormones are the problem. It is not needed for everyone and should be prescribed at the lowest effective dose, with monitoring for side effects and confirmation that ovulation has returned.
What should I do if I become pregnant while taking medicine for non-classic CAH?
Do not stop or change a prescribed glucocorticoid on your own, because sudden withdrawal can cause dangerous adrenal insufficiency. Contact your endocrinologist and obstetric team promptly so they can review medication safety and decide whether you need a stress-dose plan for serious illness or labor.
Does my partner need genetic testing before we try to conceive?
Yes, validated carrier testing for your partner can help clarify the chance that a child will have non-classic or classic CAH. Because CYP21A2 testing can be complex, a genetic counselor may recommend specialized sequencing and interpret the results alongside your genetic report.
Does non-classic CAH increase the risk of miscarriage?
Non-classic CAH may be associated with a slightly higher risk of early miscarriage than in the general population. Studies on glucocorticoids for preventing miscarriage are inconsistent, so these medicines are not a universal miscarriage-prevention treatment.

Get notified when new evidence is published on Congenital adrenal hyperplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.

    Carmina E, Dewailly D, Escobar-Morreale HF, et al.

    Human reproduction update 2017; (23(5)):580-599 doi:10.1093/humupd/dmx014.

    PMID: 28582566
  2. 2

    Pregnancy in women with nonclassic congenital adrenal hyperplasia: Time to conceive and outcome.

    Eyal O, Ayalon-Dangur I, Segev-Becker A, et al.

    Clinical endocrinology 2017; (87(5)):552-556 doi:10.1111/cen.13429.

    PMID: 28731586
  3. 3

    Fertility and pregnancy outcomes in women with nonclassic 21-hydroxylase deficiency.

    Carrière C, Nguyen LS, Courtillot C, et al.

    Clinical endocrinology 2023; (98(3)):315-322 doi:10.1111/cen.14842.

    PMID: 36325983
  4. 4

    Reproduction and fertility issues in women with congenital adrenal hyperplasia: pathophysiology, management, and recent clinical advances.

    Anaforoğlu İ, Ertörer ME

    Hormones (Athens, Greece) 2026; doi:10.1007/s42000-026-00808-w.

    PMID: 42443698
  5. 5

    MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency.

    Nordenström A, Falhammar H

    European journal of endocrinology 2019; (180(3)):R127-R145.

    PMID: 30566904
  6. 6

    Female Pelvic Conditions: Polycystic Ovary Syndrome.

    Wilkinson LD, Brady PH, Gin GT, Rosenblum E

    FP essentials 2022; (515()):26-31.

    PMID: 35420404
  7. 7

    Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis.

    Guo X, Zhang Y, Yu Y, et al.

    Frontiers in endocrinology 2022; (13()):982953 doi:10.3389/fendo.2022.982953.

    PMID: 36120452
  8. 8

    The Cycle Characteristics and Outcomes of Infertile Nonclassic 21-Hydroxylase Deficiency Patients Undergoing Ovarian Stimulation for In Vitro Fertilization.

    Jiang S, Kuang Y

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2019; (51(5)):315-325 doi:10.1055/a-0893-3122.

    PMID: 31071736
  9. 9

    Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence

    Peltek Kendirci HN, Ünal E, Dündar İ, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.

    PMID: 39713876
  10. 10

    The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.

    Maher JY, Gomez-Lobo V, Merke DP

    Reviews in endocrine & metabolic disorders 2023; (24(1)):71-83 doi:10.1007/s11154-022-09770-5.

    PMID: 36399318

This page provides general information about non-classic CAH, fertility, and pregnancy; it is not medical advice. Your endocrinologist, fertility specialist, and obstetric team should personalize medication, genetic counseling, and pregnancy care.